Endovascular Engineering (E2) announced today that it raised $42 million in an oversubscribed Series B financing round.

"Endovascular Engineering secures $42m for clot removal technology platform" was originally created and published by Medical ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...

HealthDay News — (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion, according ...

The American Heart Association/American Stroke Association 2019 Guidelines for the Early Management of Patients with Acute Ischemic Stroke recommends mechanical clot removal within 24 hours of ...

The standard treatment for these strokes involves removing the clot using a thin tube (catheter) or a stent, a procedure ...

According to the study protocols, 127 patients received tenecteplase and successfully underwent endovascular therapy, and 129 received standard medical ... care after clot removal compared to ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

compared to people receiving standard medical treatment after clot removal. In this trial, standard care was clot removal without clot-dissolving medication. The added treatment may work by ...